This white paper highlights the challenges of emerging and re-emerging infectious diseases such as TB, MSSA/MRSA, and Ebola. At Q2 Solutions, we support infectious disease clinical trials with a...
Data collected from clinical trials helps advance the field of medicine, and both the usage and sharing of clinical trial data are important in drug development. In order to improve the efficiency...
Download this presentation to learn more about the challenges and the importance of neutralizing antibodies assays and immunogenicity strategy in drug development to assess and mitigate risk....
Dr. Patrice Hugo recently co-authored a white paper with IQVIA about restarting clinical trials in Asia Pacific following the COVID-19 pandemic. The recent restrictions imposed by many countries in...